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Background/Aims: Epidemiological evidence indicates an inverse associ-
ation between nut consumption and obesity, inﬂammation, hyper-
lipidaemia and glucose intolerance. We sought to investigate whether
daily consumption of hi-oleic peanuts compared with a nut free diet
improved adiposity and cardio-metabolic risk markers.
Methods: Sixty one healthy participants (mean ± SD age 65 ± 1 years, BMI
31 ± 1 kg/m2) consumed hi-oleic peanuts (56 g/day for 32 women; 84 g/d
for 29 men) or a nut free diet for 12 weeks, in a randomised cross-over
design. Body mass, body composition (measured by dual emission x-ray
absorptiometry), C-reactive protein (CRP), lipids, glucose and insulin were
assessed at baseline and at the end of each 12-week period. Repeated
measures analysis controlling for baseline was used to compare the two
diets.
Results: Energy intake was 9 % higher (780 kJ, p < 0.05), with no difference
in energy expenditure following the peanut phase compared with the
control diet. This was attributed to a 23% (22 g) increase in fat intake (p <
0.001), predominantly monounsaturated (20 g, p < 0.05). Despite the
greater energy and monounsaturated fat intakes during the peanut phase
compared with the nut free diet, there were no differences in body weight,
body composition and other cardio-metabolic risk markers (lipids, CRP,
glucose and insulin).
Conclusions: Consumption of hi-oleic peanuts did not alter cardio-meta-
bolic biomarkers or body composition despite the additional energy and
monounsaturated fat intake. It is possible that incomplete nutrient ab-
sorption occurred, resulting in reduced energy utilisation from the peanuts.
Funding source(s): ARC, Peanut Company of Australia.
BIOFORTIFIED PRODUCE e QUEEN GARNET, A NEW HIGH ANTHOCYAN
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Background/Aims: Recent publications indicate that the consumption of
dietary anthocyanins from fresh food, juice or puree may exert protection
against cardiovascular risk factors and type 2 diabetes. The aim of this
study was to investigate the bioavailability and metabolism of anthocya-
nins from Queen Garnet plum (QGP), a new, high anthocyanin plum.
Methods: In vitro: blended QGP was subjected to simulated gastric and
small intestinal digestion and the bioaccessible anthocyanins were ana-
lysed by HPLC-photodiode array detection (PDA)-MS. In vivo: Ten healthy
men (18-35 years; mean ± SD BMI: 22.9 ± 3.2 kg/m2) consumed 400 mL
QGP juice (QGPJ; 0.95 mmol total anthocyanins and 8.6 mmol total poly-
phenols) or water (control) in a randomised cross-over design. Urinary
excretion of intact anthocyanins and metabolites was analysed up to 24 h
post-intake by HPLC-PDA-MS and NMR spectroscopy. Differences between
treatments were tested using one-way ANOVA.
Results: The amount of bioaccessible cyanidin-3-glucoside and cyanidin-
3-rutinoside from QGP was relatively high (59%) whereas the urinary
excretion, mainly as methylated, glucuronidated and sulphated metabo-
lites, was low (0.2% of the ingested dose). Urinary hippuric acid, a colonic/
hepatic polyphenol/anthocyanin “end-metabolite”, was increased 4.5-fold
(p < 0.05) after QGPJ consumption (4.35 vs. 0.97 mmol/24 h). Malondial-
dehyde was signiﬁcantly reduced (p < 0.05) after QGPJ consumption.
Conclusions: It is suggested that QGP anthocyanins are (1) readily bio-
accessible, which may be due to the high content in the ﬂesh, and (2)
subjected to an intensive metabolism in vivo which may alter theirbioactivity and subsequently “dietary value”. Follow-up studies are in
progress to investigate this further.
Funding source(s): HAL and Nutrafruit Pty Ltd.Concurrent session 6: micronutrients and
biomarkers
METALLOTHIONEIN (MT-2A) GENE EXPRESSION IS UPREGULATED
AFTER ZINC SUPPLEMENTATION IN HEALTHY INDIVIDUALS
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Background/Aims: In in vitro studies, zinc has been shown to affect the
gene expression of zinc transporters and metallothioneins (MT), which are
responsible for regulating cellular zinc homeostasis. Expression of these
genes may provide novel biomarkers of zinc status in humans.
Methods: Healthy adults (n ¼ 39) were randomised to a zinc supplement
group (20 mg elemental Zn/day; n ¼ 19) or no treatment (n ¼ 20) for 21
days. Blood samples were collected on days 0, 2, 7, 14 and 21. Plasma zinc
concentrations were analysed using Atomic Absorption Spectrometry. RNA
was extracted from peripheral blood mononuclear cells and mRNA
expression of zinc transporters, MT-1A and MT-2A were analysed using
real-time PCR. Repeated-measures ANOVA were used to test differences
between groups.
Results: Thirty-ﬁveparticipants completed the trial (zinc,n¼ 17; control,n¼
18). In the zinc group, plasma zinc concentrations increased frombaseline by
0.98 ± 0.67 mmol/L (mean ± SEM) on day 21 (p ¼ 0.316). MT-2A expressions
were signiﬁcantly different between groups (p < 0.05) with a signiﬁcant
increaseonday2 in the zinc group (35±17%,p<0.05).No signiﬁcant changes
were observed in other measured gene expression of zinc transporters.
Within-subject coefﬁcients of variation in gene expression of zinc trans-
porters and MT ranged from 19-35% (n ¼ 18). Gene expressions of zinc
transporters andMTwere not related to plasma zinc or habitual dietary zinc.
Conclusions: This pilot study showed up-regulation of MT gene expres-
sion following zinc supplementation and may be reﬂective of increased
dietary zinc intake over the preceding days.
Funding source(s): University of Sydney andMeat and Livestock Australia.
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IN VITAMIN D STATUS IN OLDER ADULTS
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Background/Aims: To investigate behavioural impact on long-term sea-
sonal vitamin D (vitD) status in older Tasmanian adults.
Methods: Seventy participants in a study investigating determinants of
vitD status returned for follow-up assessment nine months (winter) and
26 months (summer) after study completion (21 male, 49 female; mean ±
SD age 69.2 ± 6.4 years, range 60-84 years). Changes in diet, supplement
use, time spent outside, sun protection and serum vitD concentrationwere
compared between four time points (summer and winter during the study,
winter and summer follow-up) using repeated measures mixed effects
linear regression.
Results:Mean±SD serumvitD (nmol/L) in summerduring-study (68.8±22.1)
was signiﬁcantlyhigher (p<0.001) thanwinterduring-study (52.6±20.9) and
signiﬁcantly lower (p < 0.001) than summer follow-up (78.5 ± 16.7) but not
different to winter follow-up (65.8 ± 18.3). Winter during-study was signiﬁ-
cantly lower (p < 0.001) than all other time-points. During the study, 15/70
participants took vitD supplements. At nine and 26 months it was 38/70 and
42/70. There was a signiﬁcant difference in vitD status between supplement
and non-supplement groups during-study and winter follow-up (p < 0.04);
however, summer follow-up results were not different between the two
